Prot #D4190C00023: A Phase 1b Study to Evaluate the Safety and Efficacy of MEDI4736 as Monotherapy and in Combination with Tremelimumab or AZD9150 in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma

  • Pro, Barbara (PD/PI)

Project: Research project

Project Details

Effective start/end date4/29/164/29/19


  • ICON Clinical Research, LLC (Prot #D4190C00023 // Prot #D4190C00023)
  • MedImmune, LLC (Prot #D4190C00023 // Prot #D4190C00023)